X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (278690) 278690
Newspaper Article (53890) 53890
Newsletter (22619) 22619
Web Resource (4285) 4285
Magazine Article (1666) 1666
Book Chapter (1418) 1418
Dissertation (646) 646
Trade Publication Article (522) 522
Publication (362) 362
Book / eBook (337) 337
Transcript (307) 307
Conference Proceeding (224) 224
Book Review (122) 122
Reference (122) 122
Government Document (70) 70
Streaming Video (45) 45
Journal / eJournal (33) 33
Report (30) 30
Paper (19) 19
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (188926) 188926
lymphomas (123808) 123808
male (95499) 95499
female (91140) 91140
oncology (67887) 67887
middle aged (62769) 62769
cancer (60871) 60871
adult (60127) 60127
lymphoma (50887) 50887
hematology (48674) 48674
aged (48372) 48372
animals (37281) 37281
research (32760) 32760
leukemia (32723) 32723
chemotherapy (31693) 31693
adolescent (30663) 30663
child (28658) 28658
prognosis (23441) 23441
mice (22999) 22999
non-hodgkin's lymphomas (22194) 22194
care and treatment (21751) 21751
tumors (17850) 17850
child, preschool (17849) 17849
antineoplastic combined chemotherapy protocols - therapeutic use (17282) 17282
pathology (16256) 16256
aged, 80 and over (15887) 15887
treatment outcome (15836) 15836
expression (15779) 15779
apoptosis (15428) 15428
medical research (15254) 15254
diagnosis (14678) 14678
non-hodgkins-lymphoma (14314) 14314
retrospective studies (13762) 13762
lymphoma - pathology (13728) 13728
immunology (13626) 13626
patients (13533) 13533
analysis (13430) 13430
diagnosis, differential (13357) 13357
health aspects (13193) 13193
risk factors (12987) 12987
disease (12793) 12793
t cells (12491) 12491
therapy (12113) 12113
clinical trials (11987) 11987
immunohistochemistry (11830) 11830
cancer therapies (11443) 11443
transplantation (11415) 11415
genetic aspects (11183) 11183
b-cell lymphoma (11113) 11113
lymphocytes (10524) 10524
biopsy (10342) 10342
infant (10330) 10330
rituximab (10295) 10295
hemic and lymphatic diseases (10182) 10182
proteins (10049) 10049
pediatrics (9864) 9864
lymphoma, non-hodgkin - pathology (9629) 9629
gene expression (9520) 9520
young adult (9403) 9403
antineoplastic agents - therapeutic use (9361) 9361
survival (9342) 9342
cell biology (9234) 9234
children (9204) 9204
mutation (9123) 9123
pharmaceutical industry (9090) 9090
cell line, tumor (9009) 9009
medicine, general & internal (8521) 8521
immunotherapy (8489) 8489
medicine & public health (8402) 8402
stem cells (8402) 8402
surgery (8254) 8254
follow-up studies (8213) 8213
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (8181) 8181
drug therapy (8094) 8094
cell line (7935) 7935
tumor cells, cultured (7846) 7846
combined modality therapy (7816) 7816
biochemistry & molecular biology (7753) 7753
flow cytometry (7718) 7718
neoplasm staging (7613) 7613
time factors (7544) 7544
medicine (7496) 7496
oncology, experimental (7396) 7396
lymphoma, large b-cell, diffuse - pathology (7258) 7258
medicine, experimental (7206) 7206
bone marrow (7196) 7196
lymphoma - diagnosis (7156) 7156
lymphoma, non-hodgkin - drug therapy (7155) 7155
lymphoma - immunology (7101) 7101
risk (7031) 7031
multiple myeloma (6960) 6960
tomography, x-ray computed (6916) 6916
polymerase chain reaction (6854) 6854
studies (6829) 6829
medicine, research & experimental (6730) 6730
radiology, nuclear medicine & medical imaging (6696) 6696
precursor cell lymphoblastic leukemia-lymphoma - genetics (6667) 6667
acute lymphoblastic-leukemia (6663) 6663
survival rate (6583) 6583
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (198) 198
Online Resources - Online (122) 122
Collection Dvlpm't (Acquisitions) - Vendor file (19) 19
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (19) 19
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Gerstein Science - Periodical Stacks (5) 5
Scarborough Hospital - Hospital Department (5) 5
Scarborough Hospital - Online (5) 5
Robarts - Stacks (4) 4
UofT at Mississauga - Stacks (3) 3
Gerstein Science - Bindery (2) 2
Scarborough Hospital - General (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Baycrest Hospital - Wellness Library (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Theses (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Media Commons - Audio Visual (1) 1
Mt Sinai Hospital - Online (1) 1
St. Augustine's Seminary - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Toronto East General Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
University Archives - Archives (1) 1
UofT Schools - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University CRRS - Library use only (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (335870) 335870
French (7134) 7134
Japanese (6839) 6839
Spanish (3929) 3929
Chinese (3723) 3723
German (3260) 3260
Russian (2976) 2976
Polish (1455) 1455
Korean (1069) 1069
Italian (810) 810
Portuguese (636) 636
Czech (512) 512
Hungarian (394) 394
Danish (186) 186
Dutch (133) 133
Croatian (125) 125
Norwegian (121) 121
Swedish (101) 101
Hebrew (100) 100
Serbian (100) 100
Finnish (85) 85
Turkish (84) 84
Bulgarian (77) 77
Slovak (68) 68
Romanian (45) 45
Persian (38) 38
Ukrainian (29) 29
Arabic (15) 15
Greek (14) 14
Slovenian (12) 12
Lithuanian (10) 10
Bosnian (9) 9
Afrikaans (6) 6
Latvian (4) 4
Catalan (3) 3
Indonesian (3) 3
Manx (2) 2
Urdu (2) 2
Breton (1) 1
Estonian (1) 1
Galician (1) 1
Hindi (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2009, 2nd ed., ISBN 9780781791168, xiv, 597
Book
2004, ISBN 9780781735261, xix, 856
Book
1997, 2nd ed., ISBN 0340557931, xvi, 1149
Book
1990, ISBN 0683058959, xvi, 430
Book
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 1989
Journal
2014, Second edition., Cambridge medicine, ISBN 9781107010598, xi, 311 pages
Major advances have occurred in the diagnosis and treatment of lymphoma in recent years. Our understanding of the molecular biology and genetics of the disease... 
diagnosis | physiopathology | Lymphoma | therapy | Pictorial works | Lymphomas | Treatment | Diagnosis
Book
Clinical cancer research, ISSN 1557-3265, 2017, Volume 23, Issue 15, pp. 4212 - 4223
Purpose: Patients with B-cell lymphomas often relapse after frontline therapy, and novel therapies are urgently needed to provide long-term remission. We... 
ONCOLOGY | RITUXIMAB | BONE-MARROW | INVOLVEMENT | IBRUTINIB | RESISTANCE | NON-HODGKIN-LYMPHOMA | CANCER | CHEMOTHERAPY | TRANSPLANTATION | FEATURES | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Lymphomas | Mutation | Tumors | Cancer | B-cell lymphoma | patient-derived xenograft | personalized therapy
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 2010, Volume 34, Issue 3, pp. 327 - 340
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements, also known as "double-hit'' lymphomas (DHL), are rare neoplasms characterized by highly... 
BCL2 | Cytogenetics | High-grade B-cell lymphoma | MYC | Burkitt lymphoma | Diffuse large B-cell lymphoma | high-grade B-cell lymphoma | TRANSFORMATION | SURGERY | TRANSLOCATION | T(14/18) | T(14-18) | C-MYC | FOLLICULAR LYMPHOMA | diffuse large B-cell lymphoma | PATHOLOGY | cytogenetics | POLYMERASE-CHAIN-REACTION | ACUTE LYMPHOBLASTIC-LEUKEMIA | EXPRESSION | Predictive Value of Tests | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Male | Lymphoma, B-Cell - genetics | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Genes, Immunoglobulin Heavy Chain | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Time Factors | Karyotyping | Polymerase Chain Reaction | Aged, 80 and over | Burkitt Lymphoma - genetics | Adult | Female | Retrospective Studies | Child | Burkitt Lymphoma - therapy | Lymphoma, B-Cell - mortality | World Health Organization | Burkitt Lymphoma - classification | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols | Terminology as Topic | Immunophenotyping | In Situ Hybridization, Fluorescence | Treatment Outcome | Lymphoma, B-Cell - classification | Lymphoma, Large B-Cell, Diffuse - mortality | Gene Rearrangement, B-Lymphocyte, Heavy Chain | Lymphoma, Large B-Cell, Diffuse - classification | Adolescent | Lymphoma, B-Cell - pathology | Aged | Proto-Oncogene Proteins c-myc - genetics | Neoplasm Staging | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics
Journal Article
Southern Medical Journal, ISSN 0038-4348, 10/2017, Volume 110, Issue 10, pp. 614 - 620
OBJECTIVESHematological malignancies of the breast share a presentation similar to primary breast carcinomas but differ substantially in therapeutic approach... 
PRIMARY LYMPHOSARCOMA | IMPLANT CAPSULE | secondary breast lymphoma | diffuse large B-cell lymphoma | LARGE-CELL LYMPHOMA | CANCER | WOMEN | MEDICINE, GENERAL & INTERNAL | primary breast lymphoma | THERAPY | follicular lymphoma of the breast | NON-HODGKINS-LYMPHOMA | OF-THE-LITERATURE | SOFT-TISSUE SARCOMA | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Breast Neoplasms - secondary | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Middle Aged | Lymphoma, Follicular - diagnosis | Lymphoma, Mantle-Cell - pathology | Hematologic Neoplasms - pathology | Plasmacytoma - pathology | Burkitt Lymphoma - pathology | Lymphoma, Mantle-Cell - diagnosis | Lymphoma, Large-Cell, Anaplastic - diagnosis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Aged, 80 and over | Adult | Female | Lymphoma - pathology | Lymphoma, B-Cell, Marginal Zone - pathology | Retrospective Studies | Hematologic Neoplasms - diagnosis | Sarcoma, Myeloid - pathology | Diagnosis, Differential | Lymphoma - diagnosis | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Carcinoma - diagnosis | Burkitt Lymphoma - diagnosis | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Plasmacytoma - diagnosis | Lymphoma, Large B-Cell, Diffuse - diagnosis | Animals | Lymphoma, B-Cell, Marginal Zone - diagnosis | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Breast Neoplasms - pathology | Lymphoma, T-Cell - diagnosis | Lymphoma, T-Cell - pathology | Aged | Breast Neoplasms - diagnosis | Lymphoma, Large-Cell, Anaplastic - pathology | Sarcoma, Myeloid - diagnosis | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 559 - 564
BACKGROUND Double‐hit lymphomas (DHLs) are collectively defined as B‐cell non‐Hodgkin lymphomas harboring rearrangements of MYC as well as B‐cell lymphoma 2... 
BCL6 (B‐cell lymphoma 6) | non‐Hodgkin lymphoma | gene rearrangement | BCL2 (B‐cell lymphoma 2) | MYC | BCL6 (B-cell lymphoma 6) | non-Hodgkin lymphoma | BCL2 (B-cell lymphoma 2) | RITUXIMAB PLUS CYCLOPHOSPHAMIDE | TRANSLOCATIONS | IN-VIVO EFFICACY | DOXORUBICIN | B-CELL LYMPHOMA | PREDNISONE | BCL6 | ONCOLOGY | VINCRISTINE | EXPRESSION | Doxorubicin - therapeutic use | Prognosis | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Bone Marrow Neoplasms - genetics | Lymphoma, B-Cell - genetics | Cyclophosphamide - therapeutic use | Lymphoma, Non-Hodgkin - pathology | Burkitt Lymphoma - pathology | Burkitt Lymphoma - genetics | Female | Burkitt Lymphoma - drug therapy | Databases, Factual | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Ifosfamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Central Nervous System Neoplasms - genetics | Etoposide - therapeutic use | Survival Rate | Germinal Center - pathology | Lymphoma, Non-Hodgkin - genetics | DNA-Binding Proteins - genetics | Genes, bcl-2 - genetics | Rituximab - administration & dosage | Central Nervous System Neoplasms - pathology | Dexamethasone - therapeutic use | Bone Marrow Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Genes, myc - genetics | Lymphoma, B-Cell - pathology | Vincristine - therapeutic use | Bone Marrow Neoplasms - drug therapy | Central Nervous System Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Cohort Studies | Proto-Oncogene Proteins c-bcl-6 | Care and treatment | Chemotherapy | Usage | Non-Hodgkin's lymphomas | Diagnosis | Research | Oncogenes | Cancer
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 2018, Volume 19, Issue 9, p. 2475
With the introduction of next generation sequencing methods, such as RNA sequencing, it has become apparent that alterations in the non-coding regions of our... 
B-cell development | Burkitt lymphoma (BL) | Mantle cell lymphoma (MCL) | Gene regulation | Diffuse large b-cell lymphoma (DLBCL) | Circular RNA | Chronic lymphocytic leukemia (CLL) | Acute lymphoblastic leukemia (ALL) | Long non-coding RNA | Multiple myeloma (MM) | MULTIPLE-MYELOMA | chronic lymphocytic leukemia (CLL) | acute lymphoblastic leukemia (ALL) | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, MULTIDISCIPLINARY | SOMATIC MUTATIONS | TRANSCRIPTIONAL FINGERPRINTS | diffuse large B-cell lymphoma (DLBCL) | burkitt lymphoma (BL) | BURKITT-LYMPHOMA | gene regulation | circular RNA | POOR-PROGNOSIS | PROFILING REVEALS | long non-coding RNA | mantle cell lymphoma (MCL) | multiple myeloma (MM) | EXPRESSION | PROMOTES | LNCRNA | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Humans | Gene Expression Regulation, Neoplastic | Lymphoma, Mantle-Cell - pathology | Multiple Myeloma - immunology | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | RNA - genetics | Burkitt Lymphoma - pathology | RNA, Long Noncoding - immunology | Lymphoma, Follicular - genetics | Burkitt Lymphoma - immunology | Cell Transformation, Neoplastic - genetics | Burkitt Lymphoma - genetics | Lymphoma, Large B-Cell, Diffuse - immunology | Cell Differentiation | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Lymphoma, Mantle-Cell - genetics | Lymphoma, Large B-Cell, Diffuse - pathology | RNA - immunology | Signal Transduction | Lymphoma, Follicular - pathology | RNA, Long Noncoding - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Cell Transformation, Neoplastic - immunology | Multiple Myeloma - pathology | B-Lymphocytes - immunology | Lymphoma, Follicular - immunology | Lymphoma, Mantle-Cell - immunology | Cell Transformation, Neoplastic - pathology | Lymphoma, Large B-Cell, Diffuse - genetics | Multiple Myeloma - genetics | Transformation | Deregulation | Leukemia | Differentiation (biology) | Multiple myeloma | Effector cells | Genomes | Malignancy | Gene sequencing | Peripheral blood | Bone marrow | Clonal selection | Chronic lymphatic leukemia | Acute lymphatic leukemia | V(D)J recombination | Lymphatic leukemia | Gene expression | Ribonucleic acid--RNA | Burkitt's lymphoma | Somatic hypermutation | Blood circulation | Lymphocytes B | Mantle cell lymphoma | Lymphomas | Cancer | B-cell lymphoma | Genomics | Metastasis | Kinases | Proteins | Next-generation sequencing | Transfer RNA | Enzymes | Cyclin-dependent kinases | Acids | Protein synthesis | MicroRNAs | Binding sites
Journal Article
JAMA ophthalmology, ISSN 2168-6165, 04/2016, Volume 134, Issue 4, pp. 406 - 414
Journal Article
Investigational new drugs, ISSN 1573-0646, 2018, Volume 37, Issue 2, pp. 297 - 306
Purpose This first-in-human study evaluated SGN-CD70A, an antibody-drug conjugate (ADC) directed against the integral plasma membrane protein CD70 and linked... 
Mantle-cell lymphoma | Medicine & Public Health | Pyrrolobenzodiazepine dimer (PBD) | Grade 3 follicular lymphoma | Diffuse, large B cell, lymphoma (DLBCL) | Oncology | Pharmacology/Toxicology | CD70 antigen | Antibody-drug conjugate | Diffuse | large B cell | ONCOLOGY | lymphoma (DLBCL) | PLUS RITUXIMAB | PHARMACOLOGY & PHARMACY | OUTCOMES | Prognosis | Follow-Up Studies | CD27 Ligand - antagonists & inhibitors | Humans | Middle Aged | Lymphoma, Mantle-Cell - pathology | Salvage Therapy | Immunoconjugates - pharmacokinetics | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Male | Lymphoma, Large B-Cell, Diffuse - metabolism | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Tissue Distribution | CD27 Ligand - metabolism | Lymphoma, B-Cell - immunology | Aged, 80 and over | Biomarkers, Tumor - metabolism | Immunoconjugates - therapeutic use | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - metabolism | Lymphoma, B-Cell - drug therapy | CD27 Ligand - immunology | Lymphoma, B-Cell - metabolism | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Neoplasm Recurrence, Local - metabolism | Antibodies, Monoclonal - pharmacokinetics | Lymphoma, Mantle-Cell - drug therapy | Maximum Tolerated Dose | Lymphoma, Mantle-Cell - immunology | Lymphoma, B-Cell - pathology | Benzodiazepines - chemistry | Pyrroles - chemistry | Aged | Drug Resistance, Neoplasm - drug effects | Antimitotic agents | Complications and side effects | Genetic aspects | Dosage and administration | Non-Hodgkin's lymphomas | Research | Drug therapy | Antineoplastic agents | Thrombocytopenia | Anemia | Fatigue | Nausea | Exposure | Lymphoma | Patients | Anticancer properties | Membrane proteins | Proteins | Studies | Lymphocytes B | Mantle cell lymphoma | Antitumor activity | Remission | Lymphomas | Dimers | Mantle | Drug dosages | B-cell lymphoma | Phase I Studies
Journal Article
Journal Article